Thirdly, it was proposed and documented that some cases of 'tobacco amblyopia' were in fact Leber's hereditary optic neuropathies (LHON) and, possibly, which is less understood, epidemic optic neuropathies in Tanzania, Cuba, or Nigeria. 5 The patient presented in the article had probably some major nutritional deficiencies, although there was no description of tests for vitamin B12 or foliate acid in serum, etc, which could confirm this diagnosis. The LHON and other epidemic causes of optic neuropathy are probably very unlikely in this case. Thus, in my opinion, the patient should be diagnosed as having nutritional optic neuropathy.
I believe that the term 'tobacco optic neuropathy' should be reserved only for such cases, where the otherFthat is nutritional, genetic, as well as toxic or infectiousF causes can be excluded. There is also one more argument against using the name 'tobacco amblyopia', neither is it caused by tobacco itself (it might be an additional or accompanying factor), nor is it real amblyopia. Case report A 23-year-old male, a known case of FA, presented with decreasing left eye vision of 15 days duration. On examination, the best-corrected visual acuity (BCVA) was 6/6 and light perception in the right and left eye respectively. Intraocular pressure was 20 and 6 mmHg in the right and the left eye respectively. Right eye examination was unremarkable. Left eye showed sub-conjunctival haemorrhage, diffuse corneal oedema with Descemet's folds, pigmented keratitic precipitates, distorted pupil, and a complicated cataract (Figure 1 ). The fundus could not be visualized. Ultrasound B-Scan of the left eye revealed an echo-free vitreous cavity with attached retina. Integrity of the visual pathway was confirmed with ERG and VEP.
Haematological evaluation revealed haemoglobin of 7.2 g%, haematocrit 13.30%, total leukocyte count 2100 and low platelet count. Blasts were absent. Systemic vasculitic disorders were ruled out. Doppler scan of the carotids was normal.
The patient received alternate day blood transfusions and oral steroid therapy, for a period of 10 days, monitored by a haematologist. Topically prednisolone acetate 1% eye drops 6 times/day, in weekly tapering doses, and atropine sulphate 1% eye drops 3 times/day was administered. On follow-up, 1 month later, BCVA was 20/600, intraocular pressure was 9 mmHg, corneal oedema had reduced, and iris showed generalized atrophy. There was no evidence of iris neovascularization. The patient was subsequently lost to follow-up. Figure 1 Clinical photograph of the left eye showing dispersed sub-conjunctival haemorrhage, diffuse corneal oedema with Descemet's folds, pigmented keratic precipitates, distorted pupil, and a complicated cataract.
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Severe anaemia, with decreased haemoglobin content, lowers the 'oxygen availability', to various parts of the body. 3 Ocular findings reported include sub-conjunctival haemorrhage, orbital or eyelid haematoma, hyphema, and fundus findings. 4, 5 In this patient, severe anaemia probably led to ischaemic damage of the small vessel wall. This led to bleeding (sub-conjunctival haemorrhage). Besides this, generalized reduction in ocular 'oxygen availability' probably led to ischaemia of the ciliary body. This resulted in diminished aqueous production, anterior segment inflammation, and complicated cataract. These features were suggestive of anterior segment ischaemia.
In haematological disorders as FA, blood parameters should be monitored and strictly controlled, to prevent ocular complications, arising from decreased oxygen yield.
